All In MedTech

FDA Clearance Tracker · P810006-S032

COLLASTAT ABSORBABLE COLLAGEN HEMOSTATIC AGENTS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 26, 2009 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 26, 2009

Approved

Time to decision

52 days

Received Feb 2, 2009. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P810006-S032
Device name
COLLASTAT ABSORBABLE COLLAGEN HEMOSTATIC AGENTS
Applicant location
Planisboro, NJ
Received
Feb 2, 2009
Decided
Mar 26, 2009
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P810006

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AN ALTERNATE PRODUCTION FACILITY LOCATED AT INTEGRA NEUROSCIENCES PR, INC., FOR SEVERAL PRODUCTION STEPS FOR THE DEVICES.

Source documents

Other decisions for Integra LifeSciences Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.